8-K
Current Report
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-19-197230
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d754496d8k.htm…